首页> 外文期刊>Scientific reports. >Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS
【24h】

Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS

机译:预测乳腺成像报告和数据系统(BI-RADS)超声类别4或5病变中的乳腺癌:组合射频和BI-RAD的载体

获取原文
       

摘要

Radiomics reflects the texture and morphological features of tumours by quantitatively analysing the grey values of medical images. We aim to develop a nomogram incorporating radiomics and the Breast Imaging Reporting and Data System (BI-RADS) for predicting breast cancer in BI-RADS ultrasound (US) category 4 or 5 lesions. From January 2017 to August 2018, a total of 315 pathologically proven breast lesions were included. Patients from the study population were divided into a training group (n?=?211) and a validation group (n?=?104) according to a cut-off date of March 1supst/sup, 2018. Each lesion was assigned a category (4A, 4B, 4C or 5) according to the second edition of the American College of Radiology (ACR) BI-RADS US. A radiomics score was generated from the US image. A nomogram was developed based on the results of multivariate regression analysis from the training group. Discrimination, calibration and clinical usefulness of the nomogram for predicting breast cancer were assessed in the validation group. The radiomics score included 9 selected radiomics features. The radiomics score and BI-RADS category were independently associated with breast malignancy. The nomogram incorporating the radiomics score and BI-RADS category showed better discrimination (area under the receiver operating characteristic curve [AUC]: 0.928; 95% confidence interval [CI]: 0.876, 0.980) between malignant and benign lesions than either the radiomics score (P?=?0.029) or BI-RADS category (P?=?0.011). The nomogram demonstrated good calibration and clinical usefulness. In conclusion, the nomogram combining the radiomics score and BI-RADS category is potentially useful for predicting breast malignancy in BI-RADS US category 4 or 5 lesions.
机译:通过定量分析医学图像的灰度值来反映肿瘤的纹理和形态特征。我们的目标是开发一种纳米图,其结合着辐射族和乳房成像报告和数据系统(BI-RAD),用于预测Bi-Rads超声(US)类别4或5类病变中的乳腺癌。从2017年1月到2018年8月,共用了315例病理证明乳房病变。根据3月1日3月1日的截止日期,研究人群的患者分为训练组(N?=?211)和验证组(N?=?104),2018年3月1日的截止日期。根据美国放射学院(ACR)Bi-Rads的第二版,每个病变分配了一个类别(4A,4B,4C或5)。从美国图像产生了辐射瘤分数。基于培训组的多元回归分析结果开发了一个拓图。在验证组中评估了预测乳腺癌的鉴别,校准和临床用途。放射体分数包括9个选定的射频特征。辐射瘤评分和Bi-Rads类别与乳腺恶性肿瘤独立相关。包含辐射瘤评分和Bi-Rads类别的铭文显示出更好的识别(接收器操作特性曲线的区域):0.928; 95%置信区间[CI]:0.876,0.980),恶性和良性病变之间的症状和良性病变多于射索分数(p?= 0.029)或Bi-rads类别(p?= 0.011)。载体图表显示了良好的校准和临床用途。总之,结合着辐射瘤评分和Bi-rads类别的载体图可能是对预测Bi-Rads美国类别4或5病变中的乳腺恶性肿瘤的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号